期刊文献+

Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells 被引量:5

Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells
下载PDF
导出
摘要 AIM: To study the effects of cortactin on the tumor biology of SGC-7901 cells and identify the mechanism involved in the process. METHODS: Cell lines in which cortactin was stably overexpressed or knocked down as well as the respective control cell lines were established by standard molecular methods. The effects of cortactin on the proliferation, migration and invasion capacity of SGC-7901 cells were assessed by the MTT assay, colony formation, flow cytometry, transwell migration and matrigel invasion. Nude mouse models were also used to assess the role of cortactin in the growth and metastasis of SGC-7901 cells in vivo. Western blotting analysis was performed to detect the expression of epidermal growth factor receptor (EGFR) and downstream molecules. RESULTS: Cell lines in which cortactin was stably overexpressed or knocked down as well as control cell lines were successfully established and designated as LV5-cortactin-SGC, LV5-SGC, LV3-shRNA-SGC and LV3SGC. Cortactin overexpression promoted SGC-7901 cell migration (340.7 +/- 12.6 vs 229.1 +/- 23.2, P < 0.01) and invasion (71.6 +/- 5.2 vs 48.4 +/- 3.6, P < 0.01). Cortactin downregulation impaired SGC-7901 cell migration (136.2 +/- 19.8 vs 225 +/- 17) and invasion (29.2 +/- 5.2 vs 49.6 +/- 3.8, P < 0.01). The results from the MTT and colony formation assays results indicated increased LV5-cortactin-SGC cell proliferation and decreased LV3shRNA-SGC cell proliferation compared to the control cells. Flow cytometry analysis demonstrated that cortactin overexpression promoted the proliferation index of SGC-7901 cells, and the results were reversed when cortactin was downregulated. Mouse tumor models confirmed that cortactin expression increased SGC-7901 cell proliferation and metastasis in vivo. Western blotting analysis revealed that cortactin elevated EGFR expression and activated the downstream molecules. CONCLUSION: Cortactin expression promoted the migration, invasion and proliferation of SGC-7901 cells both in vivo and in vitro. The EGFR signaling pathway is mechanistically involved. (c) 2014 Baishideng Publishing Group Co., Limited. All rights reserved. AIM:To study the effects of cortactin on the tumor biology of SGC-7901 cells and identify the mechanism involved in the process.METHODS:Cell lines in which cortactin was stably overexpressed or knocked down as well as the respective control cell lines were established by standard molecular methods.The effects of cortactin on the proliferation,migration and invasion capacity of SGC-7901cells were assessed by the MTT assay,colony formation,flow cytometry,transwell migration and matrigel invasion.Nude mouse models were also used to assess the role of cortactin in the growth and metastasis of SGC-7901 cells in vivo.Western blotting analysis was performed to detect the expression of epidermal growth factor receptor(EGFR)and downstream molecules.RESULTS:Cell lines in which cortactin was stably overexpressed or knocked down as well as control cell lines were successfully established and designated as LV5-cortactin-SGC,LV5-SGC,LV3-shRNA-SGC and LV3-SGC.Cortactin overexpression promoted SGC-7901 cell migration(340.7±12.6 vs 229.1±23.2,P<0.01)and invasion(71.6±5.2 vs 48.4±3.6,P<0.01).Cortactin downregulation impaired SGC-7901 cell migration(136.2±19.8 vs 225±17)and invasion(29.2±5.2vs 49.6±3.8,P<0.01).The results from the MTT and colony formation assays results indicated increased LV5-cortactin-SGC cell proliferation and decreased LV3-shRNA-SGC cell proliferation compared to the control cells.Flow cytometry analysis demonstrated that cortactin overexpression promoted the proliferation index of SGC-7901 cells,and the results were reversed when cortactin was downregulated.Mouse tumor models confirmed that cortactin expression increased SGC-7901cell proliferation and metastasis in vivo.Western blotting analysis revealed that cortactin elevated EGFR expression and activated the downstream molecules.CONCLUSION:Cortactin expression promoted the migration,invasion and proliferation of SGC-7901 cells both in vivo and in vitro.The EGFR signaling pathway is mechanistically involved.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第12期3287-3300,共14页 世界胃肠病学杂志(英文版)
基金 Supported by Grants from the Project of Shanghai Science and Technology Commission of China,No.10411968400
关键词 Gastric cancer CORTACTIN Epidermal growth factor receptor INVASION METASTASIS PROLIFERATION Gastric cancer Cortactin Epidermal growth factor r
  • 相关文献

参考文献12

  • 1Jia Song,Xiu-Lan Peng,Meng-Yao Ji,Ming-Hua Ai,Ji-Xiang Zhang,Wei-Guo Dong.Hugl-1 induces apoptosis in esophageal carcinoma cells both in vitro and in vivo[J].World Journal of Gastroenterology,2013,19(26):4127-4136. 被引量:4
  • 2Jan Harder,Oliver Waiz,Florian Otto,Michael Geissler,Manfred Olschewski,Brigitte Weinhold,Hubert E Blum,Annette Schmitt-Graeff,Oliver G Opitz.EGFR and HER2 expression in advanced biliary tract cancer[J].World Journal of Gastroenterology,2009,15(36):4511-4517. 被引量:18
  • 3Marta Rokita,Lubomir Bodnar,Cezary Szczylik,Rafa? Stec,Wojciech Koz?owski,Jacek Nikliński,Lech Chyczewski,Marzena Cichowicz,Marta Smoter,Jan Korniluk,Rados?aw Charkiewicz.Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system[J].OncoTargets and Therapy (default).2013(default)
  • 4Sang Jae Noh,Hyun Ah Baek,Ho Sung Park,Kyu Yun Jang,Woo Sung Moon,Myoung Jae Kang,Dong Geun Lee,Min Ho Kim,Ju Hyung Lee,Myoung Ja Chung.Expression of SIRT1 and cortactin is associated with progression of non-small cell lung cancer[J].Pathology - Research and Practice.2013(6)
  • 5Qinmin Li,Ruihua Shi,Yundong Wang,Xiaoping Niu.TAGLN suppresses proliferation and invasion, and induces apoptosis of colorectal carcinoma cells[J]. Tumor Biology . 2013 (1)
  • 6Till Sebastian Clauditz,Artur Gontarewicz,Patrick Lebok,Maria-Christina Tsourlakis,Tobias J. Grob,Adrian Münscher,Guido Sauter,Carsten Bokemeyer,Rainald Knecht,Waldemar Wilczak.Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: Potentials as therapeutic target[J].Oral Oncology.2012(10)
  • 7Wen‐Chiuan Tsai,Chih‐Kung Lin,Herng‐Sheng Lee,Hong‐Wei Gao,Shin Nieh,De‐Chuan Chan,Jong‐Shiaw Jin.The correlation of cortactin and fascin‐1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma[J].APMIS.2012(3)
  • 8Robert Pirker,Jose R Pereira,Joachim von Pawel,Maciej Krzakowski,Rodryg Ramlau,Keunchil Park,Filippo de Marinis,Wilfried EE Eberhardt,Luis Paz-Ares,Stephan St?rkel,Karl-Maria Schumacher,Anja von Heydebreck,Ilhan Celik,Kenneth J O’Byrne.EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study[J].Lancet Oncology.2012(1)
  • 9Jonah D. Klein,Apostolos Christopoulos,Sun M. Ahn,William E. Gooding,Jennifer R. Grandis,Seungwon Kim.Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma[J].Head Neck.2012(9)
  • 10Adi F. Gazdar.Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy[J].Cancer and Metastasis Reviews.2010(1)

二级参考文献44

  • 1Ooi A,Kobayashi M,Mai M,Nakanishi I.Amplification of c-erbB-2 in gastric cancer:detection in formalinfixed,paraffin-embedded tissue by fluorescence in situ hybridization.Lab Invest 1998; 78:345-351.
  • 2Takehana T,Kunitomo K,Suzuki S,Kono K,Fujii H,Matsumoto Y,Ooi A.Expression of epidermal growth factor receptor in gastric carcinomas.Clin Gastroenterol Hepatol 2003; 1:438-445.
  • 3Ito Y,Takeda T,Sasaki Y,Sakon M,Yamada T,Ishiguro S,Imaoka S,Tsujimoto M,Higashiyama S,Monden M,Matsuura N.Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.Pathol Res Pract 2001; 197:95-100.
  • 4Yoshikawa D,Ojima H,Iwasaki M,Hiraoka N,Kosuge T,Kasai S,Hirohashi S,Shibata T.Clinicopathological and prognostic significance of EGFR,VEGF,and HER2 expression in cholangiocarcinoma.Br J Cancer 2008; 98:418-425.
  • 5Nehls O,Oettle H,Hartmann JT,Hofheinz RD,Hass HG,Horger MS,Koppenh(o)fer U,Hochhaus A,Stieler J,Trojan J,Gregor M,Klump B.Capecitabine plus oxaliplatin as firstline treatment in patients with advanced biliary system adenocarcinoma:a prospective multicentre phase II trial.Br J Cancer 2008; 98:309-315.
  • 6Harder J,Riecken B,Kummer O,Lohrmann C,Otto F,Usadel H,Geissler M,Opitz O,Henss H.Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer.Br J Cancer 2006; 95:848-852.
  • 7Voravud N,Foster CS,Gilbertson JA,Sikora K,Waxman J.Oncogene expression in cholangiocarcinoma and in normal hepatic development.Hum Pathol 1989; 20:1163-1168.
  • 8Yau TK,Sze H,Soong IS,Hioe F,Khoo US,Lee AW.HER2 overexpression of breast cancers in Hong Kong:prevalence and concordance between immunohistochemistry and insitu hybridisation assays.Hong Kong Med J 2008; 14:130-135.
  • 9Carlson RW,Moench SJ,Hammond ME,Perez EA,Burstein HJ,Allred DC,Vogel CL,Goldstein LJ,Somlo G,Gradishar WJ,Hudis CA,Jahanzeb M,Stark A,Wolff AC,Press MF,Winer EP,Paik S,Ljung BM.HER2 testing in breast cancer:NCCN Task Force report and recommendations.J Natl Compr Canc Netw 2006; 4 Suppl 3:S1-S22; quiz S23-S24.
  • 10Kobayashi M,Ooi A,Oda Y,Nakanishi I.Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas:a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed,paraffin-embedded tissues.Hum Pathol 2002; 33:21-28.

共引文献25

同被引文献20

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部